Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens.

Diagnostic pathology - 4 Feb 2013

Furrer Daniela, Jacob Simon, Caron Chantal, Sanschagrin François, Provencher Louise, Diorio Caroline

Abstract excerpt

Amplification of the human epidermal growth factor receptor 2 (HER2) is a prognostic marker for poor clinical outcome and a predictive marker for therapeutic response to targeted therapies in breast cancer patients. With the introduction of anti-HER2 therapies, accurate assessment of HER2 status...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Automation, Laboratory
Share to Gene Amplification
Share to In Situ Hybridization, Fluorescence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pattern Recognition, Automated

Share to Predictive Value of Tests

Share to Receptor, ErbB-2

Share to Signal Processing, Computer-Assisted

Share to Software Design

Source

Open in PubMed Open full text

Identifiers

PMID: 23379971
DOI: 10.1186/1746-1596-8-17
PMCID: PMC3584735

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23379971-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens.PMID 23379971Read ↗

Automatic quantification of HER2 gene amplification in invasive breast cancer from chromogenic in situ hybridization whole slide imagesSemantic proximity Read ↗

Deep learning to automatically evaluate HER2 gene amplification status from fluorescence in situ hybridization imagesSemantic proximity Read ↗

Automated detection of the HER2 gene amplification status in Fluorescence <i>in situ</i> hybridization images for the diagnostics of cancer tissuesSemantic proximity Read ↗

Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis ofHER-2/neu gene amplification in breast cancer fine-needle samplesSemantic proximity Read ↗

Image analysis for bright-field HER2 in situ hybridization: validation for clinical useSemantic proximity Read ↗

High-Content, Cell-by-Cell Assessment of HER2 Overexpression and Amplification for Heterogeneity Detection in Breast CancerSemantic proximity Read ↗

Discordant results obtained for different methods of HER-2/neu testing in breast cancer--a question of standardization, automation and timing.Semantic proximity Read ↗

Cytological criteria to predict basal phenotype of breast carcinomas.Semantic proximity Read ↗

Computer-aided scoring of erb-b2 receptor tyrosine kinase 2 (HER2) gene amplification status in breast cancerSemantic proximity Read ↗

Comparison of automated silver enhanced in situ hybridisation (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of American PathologistsSemantic proximity Read ↗

Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cutoff for amplificationSemantic proximity Read ↗

ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.